Neuroimaging has become an indispensable tool in understanding the regions of susceptibility , progression of disease, and therapeutic effectiveness for the management of neurologic diseases in humans. Metabolic diseases are recognized more frequently now as the biochemical basis is understood better. In addition, and as illustrated in this issue of the AJNR [1-3] , clinicians can benefit immen...
